株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ナノ医薬品の世界市場 - 産業洞察と予測 2026年

Nanopharmaceuticals Market - Global industry Insights and Forecast till 2026

発行 Coherent Market Insights 商品コード 798081
出版日 ページ情報 英文 170 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
ナノ医薬品の世界市場 - 産業洞察と予測 2026年 Nanopharmaceuticals Market - Global industry Insights and Forecast till 2026
出版日: 2019年02月14日 ページ情報: 英文 170 Pages
概要

ナノ医薬品は、ナノテクノロジーの原理に基づいて機能する1ミクロン未満の粒子サイズの医薬品です。ナノ医薬品は、治療用化合物の担体として、または治療用化合物として薬物デリバリーに広く使用されており、特定の細胞、組織、または特定の臓器を標的とするように設計されています。

当レポートでは、世界のナノ医薬品市場を調査し、市場の概要、通信事業者タイプ・用途・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査盲的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概要

  • レポート概要
    • 市場定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:担体タイプ別
    • 市場スニペット:用途別
    • 市場スニペット:流通チャネル別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • マーケットダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • パイプライン分析
  • 償還シナリオ
  • 疫学
  • PEST分析
  • 規制シナリオ
  • 新製品の発売
  • 提携・協定
  • 市場動向

第4章 世界のナノ医薬品市場:担体タイプ別

  • イントロダクション
  • リポソーム
  • ポリマー
  • ナノクリスタル
  • 無機質
  • タンパク質
  • その他

第5章 世界のナノ医薬品市場:用途別

  • イントロダクション
  • 腫瘍
  • 神経
  • 抗炎症
  • 抗感染症
  • 心血管
  • その他

第6章 世界のナノ医薬品市場:流通経路別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 世界のナノ医薬品市場:地域別

  • イントロダクション
  • 北米
  • 中南米
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第8章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • Abbott Laboratories
    • GlaxoSmithKline plc.
    • Eli Lilly and Company
    • Astrazeneca plc.
    • Novavax, Inc.
    • Stryker Corporation
    • OSI Pharmaceuticals
    • Kadmon Pharmaceuticals
    • Samyang Biopharm
    • 田辺三菱製薬
    • 科研製薬
    • Selecta Biosciences
    • Par Pharmaceutical
    • Cerulean Pharma Inc.
    • Navidea Biopharmaceuticals
    • AbbVie Inc.
    • AMAG Pharmaceuticals
    • Amgen Inc.
    • アステラス製薬
    • Celgene Corporation
    • Gilead Sciences, Inc.
    • JOHNSON & JOHNSON
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Hoffmann-La Roche AG
    • Sanofi S.A
    • Shire Plc.
    • Teva Pharmaceuticals Industries Limited.
  • アナリストの意見

第9章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Report Description

Nanopharmaceuticals are novel medicine with particle size less than 1 micron, which work on the principle of nanotechnology. Nanopharmaceuticals are widely used in drug delivery as a carrier for therapeutic compound or as a therapeutic compound. Nanopharmaceuticals are designed to target particular cells, tissue or a specific organ.

Market Dynamics

Increasing prevalence of cardiovascular diseases, cancer, and infectious diseases are major factors driving nanopharmaceuticals market growth. The World Health Organization, factsheet September 2018, estimated around 10 million cases of tuberculosis and around 1.6 million deaths from the disease in 2017. Moreover, advantages of nanopharmaceuticals over macroscopic level medicines is expected to boost the market growth. Nanopharmaceuticals can pass the blood brain barrier and can access the remote areas of brain as well as low solubility of the compound can be developed for enhancing its characteristics.

Key features of the study:

  • This report provides in-depth analysis of the nanopharmaceuticals market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global nanopharmaceuticals market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott, GlaxoSmithKline and plc., Eli Lilly and Company, Astrazeneca plc., Novavax, Inc., Stryker Corporation, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Tanabe Pharma Corporation, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma Inc., Navidea Biopharmaceuticals, Inc., AbbVie Inc., AMAG Pharmaceuticals, Amgen Inc., Astellas Pharma Inc., Celgene Corporation, Gilead Sciences, Inc., JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global nanopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the nanopharmaceuticals market

Detailed Segmentation:

  • Global Nanopharmaceuticals Market, By Carrier:
    • Liposomes
    • Polymer
    • Nanocrystals
    • Inorganic
    • Protein
    • Others
  • Global Nanopharmaceuticals Market, By Application:
    • Oncology
    • Neurology
    • Anti-inflammatory
    • Anti-infective
    • Cardiovascular
    • Others
  • Global Nanopharmaceuticals Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Nanopharmaceuticals Market, By Geography:
    • North America
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Carrier:
      • Liposomes
      • Polymer
      • Nanocrystals
      • Inorganic
      • Protein
      • Others
      • By Application:
      • Oncology
      • Neurology
      • Anti-inflammatory
      • Anti-infective
      • Cardiovascular
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • GlaxoSmithKline plc.
    • Eli Lilly and Company
    • Astrazeneca plc.
    • Novavax, Inc.
    • Stryker Corporation
    • OSI Pharmaceuticals
    • Kadmon Pharmaceuticals
    • Samyang Biopharm
    • Mitsubishi Tanabe Pharma Corporation
    • Kaken Pharmaceutical
    • Selecta Biosciences
    • Par Pharmaceutical
    • Cerulean Pharma Inc.
    • Navidea Biopharmaceuticals
    • AbbVie Inc.
    • AMAG Pharmaceuticals
    • Amgen Inc.
    • Astellas Pharma Inc.
    • Celgene Corporation
    • Gilead Sciences, Inc.
    • JOHNSON & JOHNSON
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Hoffmann-La Roche AG
    • Sanofi S.A
    • Shire Plc.
    • Teva Pharmaceuticals Industries Limited.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Carrier Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Nanopharmaceuticals Market, By Carrier Type, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Liposomes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Polymer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Nanocrystals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Inorganic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Protein
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Nanopharmaceuticals Market, By Application, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Anti-inflammatory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Anti-infective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Nanopharmaceuticals Market, By Distribution Channel, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Nanopharmaceuticals Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Carrier Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Countryt 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Carrier Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Carrier Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Carrier Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Carrier Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Carrier Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Abbott Laboratories
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Astrazeneca plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novavax, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Stryker Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • OSI Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kadmon Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Samyang Biopharm
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mitsubishi Tanabe Pharma Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kaken Pharmaceutical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Selecta Biosciences
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Par Pharmaceutical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cerulean Pharma Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Navidea Biopharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AMAG Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amgen Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Astellas Pharma Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Celgene Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gilead Sciences, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • JOHNSON & JOHNSON
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hoffmann-La Roche AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shire Plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceuticals Industries Limited.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top